The White House announced Friday that nine additional pharmaceutical companies have agreed to follow President Trump's 'most favored nation' drug pricing policy, with some of the companies throwing in several months' worth of emergency drug supplies. According to a senior administration official, the following companies will abide by Trump's MFN pricing policy: Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Genentech, Gilead Sciences, GSK, Merck & Co., Novartis and Sanofi.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
